Our News Bureau – Mumbai
Pharmaceuticals Export Promotion Council of India (Pharmexcil) is organising India Show in CPhI Worldwide 2012 at Madrid, Spain. Ministry of Commerce and Industry, Government of India has initiated a Brand India Pharma Campaign to position India as ‘pharmacy of the world’. The campaign is being carried out by Pharmexcil in association with India Brand Equity Foundation (IBEF). As part of Brand India Pharma Campaign, this is the first time that Government of India has approved a pharma sector specific India show.
Anand Sharma, Minister of Commerce, Industry and Textile, and top senior government officials are participating in the event. Drugs Controller General of India (DCGI) and other drug regulators from some states are also participating in India Show. Over 250 companies from India are participating in this global event. India is the focus country during this edition of CPhI World Wide and Sharma will be the Chief Guest during the inaugural ceremony.
Over the years, India has emerged as major exporters of generic pharmaceuticals products with a strong manufacturing base. In conjunction with the country’s rich vendor base, India is also emerging as hub for contract research, bio-technology, clinical trials and clinical data management.
The key objective is to bring global recognition to pharma developed and manufactured from India which are high quality, authentic, and safe, but also affordable. The need for such a strategy is strengthened further in view of reports in various market places about concerns on quality of pharma products sourced from India which affects the brand image of the Indian pharma industry. At the same time it calls for initiating sustained activities to challenge and dispel wrongly propagated ideas about Indian pharma mainly generics.
The campaign includes specific objectives such as: to raise the awareness of the Indian pharma success story and improve the credibility of the Indian pharma market; to create awareness that Indian generics are not counterfeits and are, in fact, genuine medicines of exceptional standards and quality; to position India as global pharmacy of world; to respond to dubious allegations about this market by vested interests; to highlight the growth drivers: government support, strong regulatory framework, cost efficiencies, and technical capabilities and to increase business on a sustainable basis and take it to the next orbit.
A huge India pavilion and a theme pavilion has been constructed. Pharmexcil will organise the following activities during the event: Press Conference and media interviews highlighting India’s pharma sector and its strength; showcasing of products from India by Council’s members in India Pavilion; global buyer seller meetings in India theme pavilion; business seminar/panel discussions involving prominent Indian and global CEOs; FDA centre representing Indian and global regulators.
Minister of Commerce, Industry and Textile will be hosting a dinner reception on October 10, 2012. An Indian cultural programme will also be organised on the same day during the reception. A large number of CEOs, buyers, distributors and other stake holders are expected to participate in the activities being organised by Pharmexcil and IBEF with the support from Ministry of Commerce, Govt of India.
EP News Bureau